Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
NCT04088370 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-11-25
Summary
Inflammatory responses in response to alcohol have been identified as contributing to the development of alcoholic hepatitis. The inflammatory response including that to LippoPolySaccharide is known to lead to progression of alcoholic liver disease. In addition to the inflammatory response mitochondrial perturbations exist and redox homeostasis is altered in patients with alcoholic hepatitis. Though this is known there have been very few studies targeting mitochondrial function in Peripheral Blood Mononuclear Cells (PBMCs). We plan to collect 50 milliliters of blood from healthy control patients so that we can compare the data to that of patients with alcoholic hepatitis and those who are heavy drinkers without liver disease. In addition to studying mitochondrial function we will investigate cytokine response, as well as fatty acid metabolism, glucose, and insulin measurements
Conditions
- Alcoholic Hepatitis
Interventions
- OTHER
-
Blood Draw
Blood Draw Only
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-08
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of MHE in Patients With Liver Diseases
NCT04058327 ·Status: COMPLETED
-
Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis
NCT02389127 ·Status: COMPLETED
-
Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.
NCT06403332 ·Status: RECRUITING ·Phase: NA
-
Influence of Adiponutrin in Chronic Liver Disease
NCT01122797 ·Status: COMPLETED
-
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium
NCT02172898 ·Status: COMPLETED
-
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
NCT02786836 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Metobolomics in the Characterisation of HE
NCT06245473 ·Status: COMPLETED
-
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
NCT05294744 ·Status: RECRUITING ·Phase: NA
-
Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis
NCT03225677 ·Status: RECRUITING
-
Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
NCT07053709 ·Status: NOT_YET_RECRUITING
-
Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis
NCT00992888 ·Status: COMPLETED ·Phase: NA
-
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
NCT02084160 ·Status: COMPLETED
-
Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as a Prognostic Predictor Among Patients With Acute on Top of Chronic Liver Cell Failure
NCT06857682 ·Status: ACTIVE_NOT_RECRUITING
-
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy
NCT03306498 ·Status: UNKNOWN
-
BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis
NCT00736840 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
NCT05421351 ·Status: UNKNOWN
-
cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit
NCT06838468 ·Status: ENROLLING_BY_INVITATION
-
Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury
NCT03204591 ·Status: UNKNOWN
-
N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis
NCT03069300 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure
NCT05566548 ·Status: UNKNOWN
-
Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)
NCT03625726 ·Status: UNKNOWN ·Phase: NA
-
Molecular Mechanism of Exercise in Cirrhosis
NCT05982769 ·Status: RECRUITING ·Phase: NA
-
Mitochondrial Function in Patients With Severe Liver Disease
NCT02457702 ·Status: TERMINATED ·Phase: NA
-
Microvesicles and Monocytes to Predict Mortality of Patients with Cirrhosis
NCT03837444 ·Status: COMPLETED
-
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
NCT03585257 ·Status: COMPLETED ·Phase: PHASE2